Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Diagnosing & Managing Pulmonary & Kidney Manifestations in Lupus

  |  Issue: February 2019  |  

Thomas R. Collins is a freelance writer living in South Florida.

References

  1. Tse JR, Schwab KE, McMahon M, et al. Rituximab: An emerging treatment for recurrent diffuse alveolar hemorrhage in systemic lupus erythematosus. Lupus. 2015 Jun;24(7):756–759.
  2. Liu Z, Zhang H, Liu Z, et al. Multitarget therapy for induction treatment of lupus nephritis: A randomized trial. Ann Intern Med. 2015 Jan 6;162(1):18–26.
  3. Weidenbusch M, Römmele C, Schrottle A, et al. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis. Nephrol Dial Transplant. 2013 Jan;28(1):106–111.
  4. Tumlin JA, Rovin B, Rahman MM, et al. Steroid sparing efficacy of voclosporin in active lupus nephritis: Stable kidney function and blood pressure without electrolyte complications at 48 weeks. Presented at European Renal Association-European Dialysis and Transplant Association Congress. 2017 Jun. Madrid.

Related Articles

    Labored Breathing

    Strategies to diagnose and manage dyspnea in the scleroderma patient

    Can REVEAL Tool Predict Survival in SSc-Related Pulmonary Arterial Hypertension?

    A prognostic tool developed to predict survival in patients with various forms of pulmonary arterial hypertension (PAH) is fairly accurate in predicting survival outcomes for many patients with PAH related to systemic sclerosis (SSc-PAH), according to a new study. However, the prognostic accuracy is less reliable for SSc-PAH patients with the highest risk of death….

    Lung Complications Closely Entwined with Rheumatologic Diseases

    SAN FRANCISCO—Lung involvement is a frequent and often life-threatening manifestation of the connective tissue diseases (CTDs) that are commonly encountered by rheumatologists. A variety of rheumatic diseases can affect the lungs, including systemic sclerosis, rheumatoid arthritis, vasculitis, lupus, polymyositis/dermatomyositis (PM/DM) and Sjögren’s syndrome. A panel presentation on lung disease associated with rheumatic diseases at the…